Health Committee

Thursday 13 January 2005

Members present: Mr David Hinchliffe (Chairman), John Austin, Mr Keith Bradley, Mr Simon Burns, Mr John Owen Jones, Siobhain McDonagh, Dr Doug Naysmith and Dr Richard Taylor

The Committee deliberated.

In the absence of the Chairman John Austin was called to the Chair.

Ordered, That Professor Griffith Edwards be appointed a Specialist Adviser to assist the Committee in its inquiry into the Public Health White Paper [Cm 6374].-( The Chairman.)

Resolved, That the Committee do visit University College Hospital, London in connection with its inquiry into the Influence of the Pharmaceutical Industry].-( The Chairman.)

The Influence of the Pharmaceutical Industry: Mr Eddie Gray, Senior Vice President and General Manager, and Dr Stuart Dollow, Vice President, Medical Division, GlaxoSmithKline (UK), Mr Chris Brinsmead, Marketing Co-President, and Dr John Patterson, Executive Vice President, Product Strategy, Licensing and Business Development, AstraZeneca (UK), were examined.

Dr Richard Barker, Director General, and Mr Vincent Lawton, President, Association of the British Pharmaceutical Industry, Dr David Chiswell, Chairman, BioIndustry Association and Mr Simon Clark, Chairman, British Generic Manufacturers Association, were examined.

[Adjourned till Thursday 20 January at Ten o'clock.